凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
梅花生物(600873)公告正文

梅花生物:2019年第一季度报告

公告日期 2019-04-30
股票简称:梅花生物 股票代码:600873
                        2019 年第一季度报告



公司代码:600873                              公司简称:梅花生物




         梅花生物科技集团股份有限公司

                   2019 年第一季度报告




                               1/22
                                                                2019 年第一季度报告




                                                                         目录
一、重要提示............................................................................................................................................. 3

二、公司基本情况..................................................................................................................................... 3

三、重要事项............................................................................................................................................. 5

四、附录..................................................................................................................................................... 7




                                                                            2/22
                                         2019 年第一季度报告




一、 重要提示

1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,

不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。

1.2 公司全体董事出席董事会审议季度报告。

1.3 公司负责人王爱军、主管会计工作负责人王威及会计机构负责人(会计主管人员)王爱玲保证

季度报告中财务报表的真实、准确、完整。

1.4 本公司第一季度报告未经审计。

二、 公司基本情况

2.1 主要财务数据
                                                                                  单位:元    币种:人民币
                                                                                本报告期末比上年度末增减
                                本报告期末                  上年度末
                                                                                             (%)
总资产                         18,996,599,635.44            19,065,029,237.53                        -0.36
归属于上市公司股东的净资产      9,438,174,864.02             9,110,288,587.69                          3.60
                              年初至报告期末          上年初至上年报告期末         比上年同期增减(%)
经营活动产生的现金流量净额       289,163,110.76                350,663,734.26                       -17.54
                              年初至报告期末          上年初至上年报告期末        比上年同期增减(%)
营业收入                        3,338,354,620.60             3,206,676,054.17                          4.11
归属于上市公司股东的净利润       341,739,218.88                247,924,963.50                        37.84
归属于上市公司股东的扣除非       308,017,925.09                212,424,121.71                        45.00
经常性损益的净利润
加权平均净资产收益率(%)                    3.68                        2.69           增加 0.99 个百分点
基本每股收益(元/股)                        0.11                        0.08                        37.50
稀释每股收益(元/股)                        0.11                        0.08                        37.50



非经常性损益项目和金额

√适用 □不适用
                                                                                  单位:元    币种:人民币
                               项目                                             本期金额           说明
非流动资产处置损益                                                                 -645,211.82
越权审批,或无正式批准文件,或偶发性的税收返还、减免
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合国家政策
                                                                                 53,063,272.86
规定、按照一定标准定额或定量持续享受的政府补助除外
计入当期损益的对非金融企业收取的资金占用费
企业取得子公司、联营企业及合营企业的投资成本小于取得投资时应享有被
投资单位可辨认净资产公允价值产生的收益
非货币性资产交换损益



                                                    3/22
                                             2019 年第一季度报告



委托他人投资或管理资产的损益                                                         4,910,179.86
因不可抗力因素,如遭受自然灾害而计提的各项资产减值准备
债务重组损益
企业重组费用,如安置职工的支出、整合费用等
交易价格显失公允的交易产生的超过公允价值部分的损益
同一控制下企业合并产生的子公司期初至合并日的当期净损益
与公司正常经营业务无关的或有事项产生的损益
除同公司正常经营业务相关的有效套期保值业务外,持有交易性金融资产、
衍生金融资产、交易性金融负债、衍生金融负债产生的公允价值变动损益,
                                                                                    -5,991,871.00
以及处置交易性金融资产、衍生金融资产、交易性金融负债、衍生金融负债
和其他债权投资取得的投资收益
单独进行减值测试的应收款项、合同资产减值准备转回
对外委托贷款取得的损益
采用公允价值模式进行后续计量的投资性房地产公允价值变动产生的损益
根据税收、会计等法律、法规的要求对当期损益进行一次性调整对当期损益
的影响
受托经营取得的托管费收入
除上述各项之外的其他营业外收入和支出                                                -7,211,570.40
其他符合非经常性损益定义的损益项目
少数股东权益影响额(税后)                                                             -66,246.95
所得税影响额                                                                        -5,817,019.96
                                  合计                                              38,241,532.59



2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表
                                                                                                      单位:股
股东总数(户)                                                                                          144,917
                                             前十名股东持股情况
                                                                            质押或冻结情况
                               期末持股        比例      持有有限售条
    股东名称(全称)                                                      股份                      股东性质
                                  数量         (%)        件股份数量                数量
                                                                          状态
孟庆山                         854,103,033     27.48                      质押    390,000,000       境内自然人
胡继军                         186,469,341     6.00                       质押    117,400,000       境内自然人
中国证券金融股份有限公司       151,485,962     4.87                       未知                      国有法人
杨维永                          78,810,526     2.54                       质押     50,328,300       境内自然人
王爱军                          71,316,274     2.29                       无                        境内自然人
北京隆慧投资有限公司-隆
慧汇晨战略投资私募证券投        62,000,000     1.99                       未知                        其他
资基金
梁宇博                          54,868,518     1.77           1,200,000   无                        境内自然人
梅花生物科技集团股份有限
公司-2017 年第一期员工持       29,007,028     0.93                       无                          其他
股计划



                                                       4/22
                                                           2019 年第一季度报告



             兴业证券-兴业-兴业证券
                                             24,213,836       0.78                        未知                         其他
             金麒麟 5 号集合资产管理计划
             何君                            23,449,758       0.75                         无                       境内自然人
                                                       前十名无限售条件股东持股情况
             股东名称                                     持有无限售条件流通                       股份种类及数量
                                                               股的数量                     种类                    数量
             孟庆山                                           854,103,033               人民币普通股           854,103,033
             胡继军                                           186,469,341               人民币普通股           186,469,341
             中国证券金融股份有限公司                         151,485,962               人民币普通股           151,485,962
             杨维永                                            78,810,526               人民币普通股           78,810,526
             王爱军                                            71,316,274               人民币普通股           71,316,274
             北京隆慧投资有限公司-隆慧汇晨战略
                                                               62,000,000               人民币普通股           62,000,000
             投资私募证券投资基金
             梁宇博                                            53,668,518               人民币普通股           53,668,518
             梅花生物科技集团股份有限公司-2017
                                                               29,007,028               人民币普通股           29,007,028
             年第一期员工持股计划
             兴业证券-兴业-兴业证券金麒麟 5 号
                                                               24,213,836               人民币普通股           24,213,836
             集合资产管理计划
             何君                                              23,449,758               人民币普通股           23,449,758
             上述股东关联关系或一致行动的说明            上述股东中,孟庆山、王爱军、何君为一致行动人。



             2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情况

             表

             □适用 √不适用

             三、 重要事项

             3.1 公司主要会计报表项目、财务指标重大变动的情况及原因

             √适用 □不适用
             1)资产负债表项目变动情况:                                                                       单位:万元
                                                                            增减幅
           项目            本报告期末      上年度期末        增减额                                       差异说明
                                                                             度%
以公允价值计量且其变动
                                120.49      3,432.95        -3,312.46        -96.49    主要系本期远期外汇保值业务受汇率变动影响所致
计入当期损益的金融资产
预付账款                     30,489.33      9,944.20        20,545.13       206.60     主要系本期预付原材料款项增加所致
其他流动资产                 79,304.38      51,536.32       27,768.06        53.88     主要系本期公司新增银行理财所致
在建工程                     8,479.10      202,069.65      -193,590.55       -95.80    主要系公司子公司吉林梅花项目转固所致
以公允价值计量且其变动
                             1,644.15        106.74         1,537.41        1,440.33   主要系本期远期外汇业务受汇率变动影响所致
计入当期损益的金融负债
预收款项                     22,211.38      48,585.37      -26,373.99        -54.28    主要系上年末公司加大资金回笼所致
                                                                                       主要系本期转回指定为以公允价值计量且其变动计
递延所得税负债                               309.13          -309.13        -100.00
                                                                                       入当期损益的金融资产原计提的递延所得税所致


                                                                     5/22
                                                                2019 年第一季度报告


                2)利润表项目变动情况:                                                                          单位:万元
         项目           本报告期       上年同期         增减额       增减幅度%                          差异说明
财务费用                 5,279.67       8,370.77       -3,091.10        -36.93      主要系本期汇兑损益减少所致
其他收益                 5,306.33        186.39        5,119.94        2,746.84     主要系本期公司收到政府补助增加所致
投资收益                 4,822.15       2,543.65       2,278.50         89.58       主要系外汇远期结汇收益增加所致
公允价值变动损益        -4,922.53       1,429.45       -6,351.98       -444.37      主要系本期汇率波动带动远期购汇公允价值变动所致
资产处置收益               -8.62         -16.98          8.36           49.22       主要系本期固定资产处置收益增加所致
营业外收入                 300.75        85.36          215.39          252.36      主要系本期收到其他补贴款所致
营业外支出               1,077.81        142.96         934.85          653.95      主要系子公司通辽梅花捐赠支出增加所致
                                                                                    本期味精及呈味核苷酸二钠市场价格继续保持高位,较
                                                                                    去年同期有所增长,在平滑了苏氨酸、赖氨酸等饲料产
净利润                  34,625.95      25,342.44       9,283.51         36.63       品价格下降给利润带来的不利影响的基础上,进一步给
                                                                                    公司带来了利润增长。此外,本公司在本期内获得的政
                                                                                    府补助较去年同期也有所增长。
                3)现金流量表项目变动情况:                                                                单位:万元
项目                                本报告期       上年同期         增减额        增减幅度%                  差异说明
经营活动产生的现金流量净额          28,916.31      35,066.37       -6,150.06        -17.54    主要系本期原材料付款及预付款增加所致
投资活动产生的现金流量净额          -51,901.78     -63,681.16      11,779.38        18.50     主要系子公司吉林梅花项目支出减少所致
筹资活动产生的现金流量净额          19,926.30      20,674.70        -748.40         -3.62     主要系本期受限货币资金到期解除受限所致



                3.2 重要事项进展情况及其影响和解决方案的分析说明

                √适用 □不适用
                    1.股份回购进展情况
                    公司于 2019 年 1 月 23 日、2019 年 1 月 25 日分别召开了第八届董事会第二十四次会议和第
                八届董事会第二十五次会议,会议审议通过了《关于以集中竞价交易方式回购公司股份的议案》
                和《关于进一步明确回购股份用途的议案》,于 2019 年 1 月 26 日披露了《梅花生物科技集团股
                份有限公司关于以集中竞价交易方式回购股份的回购报告书》,并于 2019 年 1 月 31 日实施了首
                次回购,截至报告期末公司通过集中竞价交易方式累计已回购股份数量为 4,089,399 股,占公司总
                股本的 0.132%。成交的最高价格为 5.30 元/股,成交的最低价格为 4.38 元/股,已支付的总金额为
                1,989.32 万元人民币(不含佣金等税费)。
                    2.西藏梅花公益基金设立进展情况
                    2019 年 4 月 10 日,公司收到西藏自治区民政厅颁发的基金会法人登记证书(统一社会信用
                代码 53540000MJY3396117),公司发起的西藏梅花公益基金会完成登记设立,未来公司将以此
                基金会为平台,通过多种措施帮助提升西藏地区基础教育水平,提高精准扶贫实效,争做优秀企
                业公民。

                3.3 报告期内超期未履行完毕的承诺事项

                □适用 √不适用




                                                                       6/22
                                          2019 年第一季度报告



   3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警

   示及原因说明

   □适用 √不适用
                                                  公司名称             梅花生物科技集团股份有限公司
                                                  法定代表人                      王爱军
                                                  日期                       2019 年 4 月 29 日


   四、 附录

   4.1 财务报表
                                       合并资产负债表
                                      2019 年 3 月 31 日
   编制单位:梅花生物科技集团股份有限公司
                                                              单位:元       币种:人民币   审计类型:未经审计
                      项目                              2019 年 3 月 31 日             2018 年 12 月 31 日
流动资产:
 货币资金                                                     1,595,859,710.83                 1,912,598,058.17
 结算备付金
 拆出资金
 交易性金融资产
 以公允价值计量且其变动计入当期损益的金融资产                     1,204,900.00                   34,329,514.50
 衍生金融资产
 应收票据及应收账款                                             574,902,611.62                  561,670,588.88
 其中:应收票据                                                  66,384,538.40                   94,412,637.55
        应收账款                                                508,518,073.22                  467,257,951.33
 预付款项                                                       304,893,290.29                   99,442,016.03
 应收保费
 应收分保账款
 应收分保合同准备金
 其他应收款                                                     106,029,951.54                  105,206,086.94
 其中:应收利息
        应收股利
 买入返售金融资产
 存货                                                         1,790,571,337.80                 1,866,338,939.81
 合同资产
 持有待售资产
 一年内到期的非流动资产
 其他流动资产                                                   793,043,840.04                  515,363,180.89
   流动资产合计                                               5,166,505,642.12                 5,094,948,385.22
非流动资产:
 发放贷款和垫款



                                                 7/22
                                          2019 年第一季度报告



 债权投资
 可供出售金融资产                                                                  663,757,354.59
 其他债权投资
 持有至到期投资
 长期应收款
 长期股权投资                                                    26,752,003.86      26,674,152.85
 其他权益工具投资                                               663,757,354.59
 其他非流动金融资产
 投资性房地产
 固定资产                                                 11,481,354,894.48       9,682,074,471.36
 在建工程                                                        84,790,979.99    2,020,696,516.14
 生产性生物资产
 油气资产
 使用权资产
 无形资产                                                  1,212,279,065.96       1,224,107,750.89
 开发支出
 商誉                                                           143,173,700.39     143,173,700.39
 长期待摊费用                                                    22,794,516.64      24,832,620.55
 递延所得税资产                                                 111,559,075.09     110,451,464.14
 其他非流动资产                                                  83,632,402.32      74,312,821.40
   非流动资产合计                                         13,830,093,993.32      13,970,080,852.31
     资产总计                                             18,996,599,635.44      19,065,029,237.53
流动负债:
 短期借款                                                  3,518,205,000.00       3,524,096,000.00
 向中央银行借款
 拆入资金
 交易性金融负债
 以公允价值计量且其变动计入当期损益的金融负债                    16,441,490.00        1,067,400.00
 衍生金融负债
 应付票据及应付账款                                        1,345,451,126.56       1,490,454,255.01
 预收款项                                                       222,113,810.67     485,853,651.90
 卖出回购金融资产款
 吸收存款及同业存放
 代理买卖证券款
 代理承销证券款
 应付职工薪酬                                                    80,463,631.40     107,636,568.86
 应交税费                                                       165,614,771.10     171,580,771.63
 其他应付款                                                     370,653,117.95     315,546,563.06
 其中:应付利息                                                  52,581,351.99      37,423,394.37
        应付股利                                                 12,037,536.00      12,037,536.00
 应付手续费及佣金
 应付分保账款


                                                 8/22
                                            2019 年第一季度报告



 合同负债
 持有待售负债
 一年内到期的非流动负债                                         1,899,021,562.30                 1,899,741,980.25
 其他流动负债
   流动负债合计                                                 7,617,964,509.98                 7,995,977,190.71
非流动负债:
 保险合同准备金
 长期借款                                                       1,167,740,625.00                 1,186,385,000.00
 应付债券
 其中:优先股
        永续债
 租赁负债
 长期应付款                                                        20,000,000.00                   20,000,000.00
 预计负债
 递延收益                                                         485,853,667.17                  486,941,452.35
 递延所得税负债                                                                                     3,091,276.31
 其他非流动负债
   非流动负债合计                                               1,673,594,292.17                 1,696,417,728.66
     负债合计                                                   9,291,558,802.15                 9,692,394,919.37
所有者权益(或股东权益):
 实收资本(或股本)                                             3,108,175,038.00                 3,108,175,038.00
 其他权益工具
 其中:优先股
        永续债
 资本公积                                                       2,151,278,978.74                 2,145,234,649.03
 减:库存股                                                        93,346,701.26                   73,449,429.00
 其他综合收益
 盈余公积                                                         560,591,076.73                  560,591,076.73
 一般风险准备
 未分配利润                                                     3,711,476,471.81                 3,369,737,252.93
 归属于母公司所有者权益(或股东权益)合计                       9,438,174,864.02                 9,110,288,587.69
 少数股东权益                                                     266,865,969.27                  262,345,730.47
   所有者权益(或股东权益)合计                                 9,705,040,833.29                 9,372,634,318.16
     负债和所有者权益(或股东权益)总计                        18,996,599,635.44               19,065,029,237.53


   法定代表人:王爱军         主管会计工作负责人:王威                  会计机构负责人:王爱玲

                                      母公司资产负债表
                                      2019 年 3 月 31 日
   编制单位:梅花生物科技集团股份有限公司
                                                                 单位:元       币种:人民币   审计类型:未经审计
                      项目                                2019 年 3 月 31 日             2018 年 12 月 31 日


                                                   9/22
                                          2019 年第一季度报告



流动资产:
 货币资金                                                       537,464,071.70    1,018,443,038.75
 交易性金融资产                                                              -
 以公允价值计量且其变动计入当期损益的金融资产                                       33,982,514.50
 衍生金融资产
 应收票据及应收账款                                             147,181,917.32     180,436,512.00
 其中:应收票据                                                  24,310,884.70      35,156,462.80
        应收账款                                                122,871,032.62     145,280,049.20
 预付款项                                                       585,414,481.73     348,423,756.51
 其他应收款                                                2,462,381,503.85       2,595,324,116.23
 其中:应收利息                                                              -
        应收股利                                                570,000,000.00    1,000,000,000.00
 存货                                                            38,258,753.01     136,561,547.71
 合同资产
 持有待售资产
 一年内到期的非流动资产                                                      -
 其他流动资产                                                   262,004,668.86      83,256,408.35
   流动资产合计                                            4,032,705,396.47       4,396,427,894.05
非流动资产:
 债权投资
 可供出售金融资产                                                                  163,469,754.00
 其他债权投资
 持有至到期投资
 长期应收款                                                2,778,120,673.64       2,797,773,904.67
 长期股权投资                                              7,262,306,562.17       6,959,037,206.48
 其他权益工具投资                                               163,469,754.00
 其他非流动金融资产
 投资性房地产
 固定资产                                                       165,400,694.66     169,180,653.78
 在建工程                                                          707,547.16          707,547.16
 生产性生物资产
 油气资产
 使用权资产
 无形资产                                                        92,178,593.52      98,340,649.80
 开发支出
 商誉
 长期待摊费用                                                    18,232,350.98      19,867,123.75
 递延所得税资产                                                   3,538,310.22         706,577.52
 其他非流动资产
   非流动资产合计                                         10,483,954,486.35      10,209,083,417.16
     资产总计                                             14,516,659,882.82      14,605,511,311.21
流动负债:


                                                 10/22
                                          2019 年第一季度报告



 短期借款                                                  1,477,335,000.00           1,766,632,000.00
 交易性金融负债
 以公允价值计量且其变动计入当期损益的金融负债                    15,737,873.50
 衍生金融负债
 应付票据及应付账款                                        2,173,268,203.80           1,742,185,673.58
 预收款项                                                       284,557,066.87         572,148,056.68
 合同负债
 应付职工薪酬                                                     7,245,084.81          10,483,128.61
 应交税费                                                        23,424,306.45            1,020,982.24
 其他应付款                                                     940,589,467.44         939,819,252.11
 其中:应付利息                                                  44,900,476.08          32,676,312.66
       应付股利                                                  12,037,536.00          12,037,536.00
 持有待售负债
 一年内到期的非流动负债                                    1,899,021,562.30           1,899,741,980.25
 其他流动负债
   流动负债合计                                            6,821,178,565.17           6,932,031,073.47
非流动负债:
 长期借款                                                       881,566,875.00         894,699,000.00
 应付债券                                                                    -
 其中:优先股
       永续债
 租赁负债
 长期应付款                                                                  -
 预计负债
 递延收益
 递延所得税负债                                                                           3,058,426.31
 其他非流动负债
   非流动负债合计                                               881,566,875.00         897,757,426.31
     负债合计                                              7,702,745,440.17           7,829,788,499.78
所有者权益(或股东权益):
 实收资本(或股本)                                        3,108,175,038.00           3,108,175,038.00
 其他权益工具
 其中:优先股
        永续债
 资本公积                                                  2,117,529,111.16           2,111,484,781.44
 减:库存股                                                      93,346,701.26          73,449,429.00
 其他综合收益
 盈余公积                                                       560,591,076.73         560,591,076.73
 未分配利润                                                1,120,965,918.02           1,068,921,344.26
   所有者权益(或股东权益)合计                            6,813,914,442.65           6,775,722,811.43
     负债和所有者权益(或股东权益)总计                   14,516,659,882.82          14,605,511,311.21
   法定代表人:王爱军         主管会计工作负责人:王威              会计机构负责人:王爱玲

                                                 11/22
                                         2019 年第一季度报告




                                            合并利润表
                                           2019 年 1-3 月
编制单位:梅花生物科技集团股份有限公司
                                                            单位:元    币种:人民币   审计类型:未经审计
                      项目                              2019 年第一季度               2018 年第一季度
一、营业总收入                                                 3,338,354,620.60            3,206,676,054.17
其中:营业收入                                                 3,338,354,620.60            3,206,676,054.17
     利息收入
     已赚保费
     手续费及佣金收入
二、营业总成本                                                 2,977,214,399.62            2,946,560,976.55
其中:营业成本                                                 2,462,379,438.30            2,438,547,426.31
     利息支出
     手续费及佣金支出
     退保金
     赔付支出净额
     提取保险合同准备金净额
     保单红利支出
     分保费用
     税金及附加                                                  53,604,672.64               57,431,205.17
     销售费用                                                   265,783,449.91              246,678,595.55
     管理费用                                                   136,553,134.18              113,917,630.83
     研发费用                                                     6,097,034.76                6,292,303.51
     财务费用                                                    52,796,669.83               83,707,688.73
     其中:利息费用                                              66,890,731.81               66,519,040.65
           利息收入                                               2,365,276.26                1,592,053.41
     资产减值损失                                                             -                  -13,873.55
     信用减值损失
  加:其他收益                                                   53,063,272.86                1,863,936.66
     投资收益(损失以“-”号填列)                              48,221,464.37               25,436,525.99
     其中:对联营企业和合营企业的投资收益                            77,851.01                 -130,446.98
     汇兑收益(损失以“-”号填列)
     净敞口套期收益(损失以“-”号填列)
     公允价值变动收益(损失以“-”号填列)                      -49,225,304.50              14,294,492.34
     资产处置收益(损失以“-”号填列)                              -86,206.91                -169,750.61
三、营业利润(亏损以“-”号填列)                              413,113,446.80              301,540,282.00
  加:营业外收入                                                  3,007,542.08                  853,552.71
  减:营业外支出                                                 10,778,117.39                1,429,552.69
四、利润总额(亏损总额以“-”号填列)                          405,342,871.49              300,964,282.02
  减:所得税费用                                                 59,083,413.81               47,539,834.17
五、净利润(净亏损以“-”号填列)                              346,259,457.68              253,424,447.85


                                                12/22
                                             2019 年第一季度报告



       (一)按经营持续性分类                                      346,259,457.68        253,424,447.85
        1.持续经营净利润(净亏损以“-”号填列)                   346,259,457.68        253,424,447.85
        2.终止经营净利润(净亏损以“-”号填列)
       (二)按所有权归属分类                                      346,259,457.68        253,424,447.85
        1.归属于母公司股东的净利润(净亏损以“-”                  341,739,218.88        247,924,963.50
号填列)
        2.少数股东损益(净亏损以“-”号填列)                        4,520,238.80          5,499,484.35
六、其他综合收益的税后净额
  归属母公司所有者的其他综合收益的税后净额
       (一)不能重分类进损益的其他综合收益
        1.重新计量设定受益计划变动额
        2.权益法下不能转损益的其他综合收益
        3.其他权益工具投资公允价值变动
        4.企业自身信用风险公允价值变动
   (二)将重分类进损益的其他综合收益
        1.权益法下可转损益的其他综合收益
        2.其他债权投资公允价值变动
        3.可供出售金融资产公允价值变动损益
        4.金融资产重分类计入其他综合收益的金额
        5.持有至到期投资重分类为可供出售金融资产
损益
        6.其他债权投资信用减值准备
        7.现金流量套期储备(现金流量套期损益的有效
部分)
        8.外币财务报表折算差额
        9.其他
  归属于少数股东的其他综合收益的税后净额
七、综合收益总额                                                   346,259,457.68        253,424,447.85
  归属于母公司所有者的综合收益总额                                 341,739,218.88        247,924,963.50
  归属于少数股东的综合收益总额                                       4,520,238.80          5,499,484.35
八、每股收益:
  (一)基本每股收益(元/股)                                                  0.11                  0.08
  (二)稀释每股收益(元/股)                                                  0.11                  0.08



本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:0 元,上期被合并方实现

的净利润为:0 元。

法定代表人:王爱军               主管会计工作负责人:王威             会计机构负责人:王爱玲

                                    母公司利润表
                                    2019 年 1-3 月
编制单位:梅花生物科技集团股份有限公司


                                                    13/22
                                           2019 年第一季度报告


                                                             单位:元    币种:人民币   审计类型:未经审计
                          项目                             2019 年第一季度              2018 年第一季度
一、营业收入                                                     2,320,801,773.43            1,963,729,608.95
  减:营业成本                                                   2,095,914,351.70            1,748,028,854.28
        税金及附加                                                  3,911,405.33                5,021,799.31
        销售费用                                                  164,742,419.30              160,005,076.68
        管理费用                                                   52,348,220.05               36,194,757.59
        研发费用                                                         7,568.34
        财务费用                                                    -7,777,899.97               4,328,349.48
        其中:利息费用                                              5,993,448.59                4,729,871.94
               利息收入                                             1,351,309.19                  543,162.22
        资产减值损失                                                            -
        信用减值损失
  加:其他收益                                                     51,357,215.68
        投资收益(损失以“-”号填列)                             41,632,829.52                7,125,863.85
        其中:对联营企业和合营企业的投资收益
        净敞口套期收益(损失以“-”号填列)
        公允价值变动收益(损失以“-”号填列)                     -49,720,388.00
        资产处置收益(损失以“-”号填列)                                      -                   -1,784.64
二、营业利润(亏损以“-”号填列)                                 54,925,365.88               17,274,850.82
  加:营业外收入                                                    2,168,497.04                  449,177.58
  减:营业外支出                                                        17,279.66                 142,238.59
三、利润总额(亏损总额以“-”号填列)                             57,076,583.26               17,581,789.81
      减:所得税费用                                                5,032,009.50                2,637,268.47
四、净利润(净亏损以“-”号填列)                                 52,044,573.76               14,944,521.34
     (一)持续经营净利润(净亏损以“-”号填列)                  52,044,573.76               14,944,521.34
     (二)终止经营净利润(净亏损以“-”号填列)
五、其他综合收益的税后净额
  (一)不能重分类进损益的其他综合收益
      1.重新计量设定受益计划变动额
      2.权益法下不能转损益的其他综合收益
      3.其他权益工具投资公允价值变动
      4.企业自身信用风险公允价值变动
  (二)将重分类进损益的其他综合收益
      1.权益法下可转损益的其他综合收益
      2.其他债权投资公允价值变动
      3.可供出售金融资产公允价值变动损益
      4.金融资产重分类计入其他综合收益的金额
      5.持有至到期投资重分类为可供出售金融资产损

      6.其他债权投资信用减值准备
      7.现金流量套期储备(现金流量套期损益的有效部



                                                   14/22
                                        2019 年第一季度报告




     8.外币财务报表折算差额
     9.其他
六、综合收益总额                                                52,044,573.76                14,944,521.34
七、每股收益:
     (一)基本每股收益(元/股)
     (二)稀释每股收益(元/股)


法定代表人:王爱军             主管会计工作负责人:王威            会计机构负责人:王爱玲

                                  合并现金流量表
                                    2019 年 1-3 月
编制单位:梅花生物科技集团股份有限公司
                                                          单位:元    币种:人民币    审计类型:未经审计
                     项目                         2019年第一季度                     2018年第一季度
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                            3,175,037,391.00                3,173,821,192.89
  客户存款和同业存放款项净增加额
  向中央银行借款净增加额
  向其他金融机构拆入资金净增加额
  收到原保险合同保费取得的现金
  收到再保险业务现金净额
  保户储金及投资款净增加额
  收取利息、手续费及佣金的现金
  拆入资金净增加额
  回购业务资金净增加额
  代理买卖证券收到的现金净额
  收到的税费返还                                              26,298,614.31                   5,631,869.45
  收到其他与经营活动有关的现金                                57,958,489.13                   8,640,422.64
     经营活动现金流入小计                                 3,259,294,494.44                3,188,093,484.98
  购买商品、接受劳务支付的现金                            2,261,533,462.67                2,091,724,202.02
  客户贷款及垫款净增加额
  存放中央银行和同业款项净增加额
  支付原保险合同赔付款项的现金
  为交易目的而持有的金融资产净增加额
  拆出资金净增加额
  支付利息、手续费及佣金的现金
  支付保单红利的现金
  支付给职工以及为职工支付的现金                           242,406,170.01                   228,323,434.54
  支付的各项税费                                           177,408,054.45                   251,812,064.50
  支付其他与经营活动有关的现金                             288,783,696.55                   265,570,049.66
     经营活动现金流出小计                                 2,970,131,383.68                2,837,429,750.72



                                               15/22
                                       2019 年第一季度报告



      经营活动产生的现金流量净额                         289,163,110.76                    350,663,734.26
二、投资活动产生的现金流量:
  收回投资收到的现金                                     108,450,000.00                     68,900,000.00
  取得投资收益收到的现金                                     47,444,793.00                  25,600,784.00
  处置固定资产、无形资产和其他长期资产收回                                                      45,000.00
的现金净额
  处置子公司及其他营业单位收到的现金净额                                 -                              -
  收到其他与投资活动有关的现金                                                             228,571,072.85
    投资活动现金流入小计                                 155,894,793.00                    323,116,856.85
  购建固定资产、无形资产和其他长期资产支付               357,412,566.39                    567,890,480.34
的现金
  投资支付的现金                                         317,500,000.00                    392,037,964.02
  质押贷款净增加额
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金
    投资活动现金流出小计                                 674,912,566.39                    959,928,444.36
      投资活动产生的现金流量净额                        -519,017,773.39                   -636,811,587.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  其中:子公司吸收少数股东投资收到的现金
  取得借款收到的现金                                   1,240,000,000.00                  1,299,190,000.00
  发行债券收到的现金
  收到其他与筹资活动有关的现金                           331,210,000.00                     26,016,707.20
    筹资活动现金流入小计                               1,571,210,000.00                  1,325,206,707.20
  偿还债务支付的现金                                   1,242,100,000.00                  1,059,000,000.00
  分配股利、利润或偿付利息支付的现金                         59,649,703.38                  33,525,249.44
  其中:子公司支付给少数股东的股利、利润
  支付其他与筹资活动有关的现金                               70,197,272.26                  25,934,417.41
    筹资活动现金流出小计                               1,371,946,975.64                  1,118,459,666.85
      筹资活动产生的现金流量净额                         199,263,024.36                    206,747,040.35
四、汇率变动对现金及现金等价物的影响                         -5,236,709.07                 -14,460,526.78
五、现金及现金等价物净增加额                             -35,828,347.34                    -93,861,339.68
  加:期初现金及现金等价物余额                         1,494,735,359.17                  2,251,099,698.34
六、期末现金及现金等价物余额                           1,458,907,011.83                  2,157,238,358.66
法定代表人:王爱军          主管会计工作负责人:王威            会计机构负责人:王爱玲

                                  母公司现金流量表
                                    2019 年 1-3 月
编制单位:梅花生物科技集团股份有限公司
                                                       单位:元      币种:人民币    审计类型:未经审计
                     项目                        2019年第一季度                     2018年第一季度
一、经营活动产生的现金流量:



                                              16/22
                                       2019 年第一季度报告



  销售商品、提供劳务收到的现金                           2,216,766,015.82           1,959,349,211.21
  收到的税费返还                                                                                   -
  收到其他与经营活动有关的现金                           1,353,780,124.71           1,690,434,913.97
    经营活动现金流入小计                                 3,570,546,140.53           3,649,784,125.18
  购买商品、接受劳务支付的现金                           1,914,818,291.08           1,764,333,805.94
  支付给职工以及为职工支付的现金                             26,919,996.60            27,147,297.19
  支付的各项税费                                              7,268,858.23            26,702,724.29
  支付其他与经营活动有关的现金                           1,345,160,042.15           1,313,729,315.08
    经营活动现金流出小计                                 3,294,167,188.06           3,131,913,142.50
         经营活动产生的现金流量净额                       276,378,952.47             517,870,982.68
二、投资活动产生的现金流量:
  收回投资收到的现金                                         30,000,000.00                         -
  取得投资收益收到的现金                                  471,632,829.52               7,125,863.85
  处置固定资产、无形资产和其他长期资产收回                                                         -
的现金净额
  处置子公司及其他营业单位收到的现金净额
  收到其他与投资活动有关的现金
    投资活动现金流入小计                                  501,632,829.52               7,125,863.85
  购建固定资产、无形资产和其他长期资产支付                     301,390.00              5,323,940.00
的现金
  投资支付的现金                                          535,000,000.00             615,000,000.00
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金
    投资活动现金流出小计                                  535,301,390.00             620,323,940.00
      投资活动产生的现金流量净额                           -33,668,560.48           -613,198,076.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  取得借款收到的现金                                      170,000,000.00             400,000,000.00
  收到其他与筹资活动有关的现金                            262,100,000.00             228,316,707.20
    筹资活动现金流入小计                                  432,100,000.00             628,316,707.20
  偿还债务支付的现金                                      458,100,000.00             470,000,000.00
  分配股利、利润或偿付利息支付的现金                         40,990,443.69            23,813,392.96
  支付其他与筹资活动有关的现金                            412,717,272.26             238,000,000.00
    筹资活动现金流出小计                                  911,807,715.95             731,813,392.96
      筹资活动产生的现金流量净额                         -479,707,715.95            -103,496,685.76
四、汇率变动对现金及现金等价物的影响                            18,356.91                      -1.62
五、现金及现金等价物净增加额                             -236,978,967.05            -198,823,780.85
  加:期初现金及现金等价物余额                            698,443,038.75             908,715,785.78
六、期末现金及现金等价物余额                              461,464,071.70             709,892,004.93
法定代表人:王爱军            主管会计工作负责人:王威            会计机构负责人:王爱玲




                                              17/22
                                       2019 年第一季度报告



4.2 首次执行新金融工具准则、新收入准则、新租赁准则调整首次执行当年年初财务报表相关项目

情况

√适用 □不适用
                                        合并资产负债表
                                                                                  单位:元    币种:人民币
                    项目               2018 年 12 月 31 日       2019 年 1 月 1 日            调整数
流动资产:
  货币资金                                  1,912,598,058.17        1,912,598,058.17                     -
  结算备付金                                                 -                       -                   -
  拆出资金                                                   -                       -                   -
  交易性金融资产                                             -                       -                   -
  以公允价值计量且其变动计入当期损益          34,329,514.50            34,329,514.50                     -
的金融资产
  衍生金融资产                                               -                       -                   -
  应收票据及应收账款                         561,670,588.88           561,670,588.88                     -
  其中:应收票据                              94,412,637.55            94,412,637.55                     -
         应收账款                            467,257,951.33           467,257,951.33                     -
  预付款项                                    99,442,016.03            99,442,016.03                     -
  应收保费                                                   -                       -                   -
  应收分保账款                                               -                       -                   -
  应收分保合同准备金                                         -                       -                   -
  其他应收款                                 105,206,086.94           105,206,086.94                     -
  其中:应收利息                                             -                       -                   -
         应收股利                                            -                       -                   -
  买入返售金融资产                                           -                       -                   -
  存货                                      1,866,338,939.81        1,866,338,939.81                     -
  合同资产                                                   -                       -                   -
  持有待售资产                                               -                       -                   -
  一年内到期的非流动资产                                     -                       -                   -
  其他流动资产                               515,363,180.89           515,363,180.89                     -
   流动资产合计                             5,094,948,385.22        5,094,948,385.22                     -
非流动资产:
  发放贷款和垫款                                             -                       -
  债权投资                                                   -                       -
  可供出售金融资产                           663,757,354.59                          -   -663,757,354.59
  其他债权投资                                               -                       -                   -
  持有至到期投资                                             -                       -                   -
  长期应收款                                                 -                       -                   -
  长期股权投资                                26,674,152.85            26,674,152.85                     -
  其他权益工具投资                                                    663,757,354.59        663,757,354.59
  其他非流动金融资产                                         -                       -                   -
  投资性房地产                                               -                       -                   -

                                              18/22
                                       2019 年第一季度报告



  固定资产                                  9,682,074,471.36    9,682,074,471.36   -
  在建工程                                  2,020,696,516.14    2,020,696,516.14   -
  生产性生物资产                                           -                   -   -
  油气资产                                                 -                   -   -
  使用权资产                                               -                   -   -
  无形资产                                  1,224,107,750.89    1,224,107,750.89   -
  开发支出                                                 -                   -   -
  商誉                                       143,173,700.39      143,173,700.39    -
  长期待摊费用                                24,832,620.55       24,832,620.55    -
  递延所得税资产                             110,451,464.14      110,451,464.14    -
  其他非流动资产                              74,312,821.40       74,312,821.40    -
   非流动资产合计                          13,970,080,852.31   13,970,080,852.31   -
     资产总计                              19,065,029,237.53   19,065,029,237.53   -
流动负债:
  短期借款                                  3,524,096,000.00    3,524,096,000.00   -
  向中央银行借款                                           -                   -   -
  拆入资金                                                 -                   -   -
  交易性金融负债                                           -                   -   -
  以公允价值计量且其变动计入当期损益            1,067,400.00        1,067,400.00   -
的金融负债
  衍生金融负债                                             -                   -   -
  应付票据及应付账款                        1,490,454,255.01    1,490,454,255.01   -
  预收款项                                   485,853,651.90      485,853,651.90    -
  卖出回购金融资产款                                       -                   -   -
  吸收存款及同业存放                                       -                   -   -
  代理买卖证券款                                           -                   -   -
  代理承销证券款                                           -                   -   -
  应付职工薪酬                               107,636,568.86      107,636,568.86    -
  应交税费                                   171,580,771.63      171,580,771.63    -
  其他应付款                                 315,546,563.06      315,546,563.06    -
  其中:应付利息                              37,423,394.37       37,423,394.37    -
         应付股利                             12,037,536.00       12,037,536.00    -
  应付手续费及佣金                                         -                   -   -
  应付分保账款                                             -                   -   -
  合同负债                                                 -                   -   -
  持有待售负债                                             -                   -   -
  一年内到期的非流动负债                    1,899,741,980.25    1,899,741,980.25   -
  其他流动负债                                             -                   -   -
   流动负债合计                             7,995,977,190.71    7,995,977,190.71   -
非流动负债:
  保险合同准备金                                           -                   -   -
  长期借款                                  1,186,385,000.00    1,186,385,000.00   -
  应付债券                                                 -                   -   -

                                              19/22
                                          2019 年第一季度报告



   其中:优先股                                                 -                           -               -
             永续债                                             -                           -               -
   租赁负债                                                     -                           -               -
   长期应付款                                    20,000,000.00             20,000,000.00                    -
   预计负债                                                     -                           -               -
   递延收益                                     486,941,452.35            486,941,452.35                    -
   递延所得税负债                                  3,091,276.31             3,091,276.31                    -
   其他非流动负债                                               -                           -               -
     非流动负债合计                            1,696,417,728.66         1,696,417,728.66                    -
         负债合计                              9,692,394,919.37         9,692,394,919.37                    -
 所有者权益(或股东权益):
   实收资本(或股本)                          3,108,175,038.00         3,108,175,038.00                    -
   其他权益工具                                                 -                           -               -
   其中:优先股                                                 -                           -               -
             永续债                                             -                           -               -
   资本公积                                    2,145,234,649.03         2,145,234,649.03                    -
   减:库存股                                    73,449,429.00             73,449,429.00                    -
   其他综合收益                                                 -                           -               -
   盈余公积                                     560,591,076.73            560,591,076.73                    -
   一般风险准备                                                 -                           -               -
   未分配利润                                  3,369,737,252.93         3,369,737,252.93                    -
   归属于母公司所有者权益合计                  9,110,288,587.69         9,110,288,587.69                    -
   少数股东权益                                 262,345,730.47            262,345,730.47                    -
     所有者权益(或股东权益)合计              9,372,634,318.16         9,372,634,318.16                    -
         负债和所有者权益(或股东权益)       19,065,029,237.53        19,065,029,237.53                    -
 总计
 各项目调整情况的说明:√适用 □不适用

        本公司自 2019 年 1 月 1 日起首次执行新金融工具准则,2019 年度已按照新金融工具准则要

 求,将可供出售金融资产期初余额对应调整至其他权益工具投资项。

                                          母公司资产负债表
                                                                                        单位:元   币种:人民币
                      项目                2018 年 12 月 31 日       2019 年 1 月 1 日             调整数
流动资产:
  货币资金                                     1,018,443,038.75       1,018,443,038.75                      -
  交易性金融资产                                                -                       -                   -
  以公允价值计量且其变动计入当期损益的            33,982,514.50          33,982,514.50                      -
金融资产
  衍生金融资产                                                  -                       -                   -
  应收票据及应收账款                            180,436,512.00          180,436,512.00                      -
  其中:应收票据                                  35,156,462.80          35,156,462.80                      -
         应收账款                               145,280,049.20          145,280,049.20                      -


                                                 20/22
                                         2019 年第一季度报告



  预付款项                                     348,423,756.51      348,423,756.51                  -
  其他应收款                                  2,595,324,116.23    2,595,324,116.23                 -
  其中:应收利息                                             -                   -                 -
         应收股利                             1,000,000,000.00    1,000,000,000.00                 -
  存货                                         136,561,547.71      136,561,547.71                  -
  合同资产                                                   -                   -                 -
  持有待售资产                                               -                   -                 -
  一年内到期的非流动资产                                     -                   -                 -
  其他流动资产                                  83,256,408.35       83,256,408.35                  -
    流动资产合计                              4,396,427,894.05    4,396,427,894.05                 -
非流动资产:
  债权投资                                                   -                   -                 -
  可供出售金融资产                             163,469,754.00                    -   -163,469,754.00
  其他债权投资                                               -                   -                 -
  持有至到期投资                                             -                   -                 -
  长期应收款                                  2,797,773,904.67    2,797,773,904.67                 -
  长期股权投资                                6,959,037,206.48    6,959,037,206.48                 -
  其他权益工具投资                                                 163,469,754.00    163,469,754.00
  其他非流动金融资产                                         -                   -                 -
  投资性房地产                                               -                   -                 -
  固定资产                                     169,180,653.78      169,180,653.78                  -
  在建工程                                         707,547.16          707,547.16                  -
  生产性生物资产                                             -                   -                 -
  油气资产                                                   -                   -                 -
  使用权资产                                                 -                   -                 -
  无形资产                                      98,340,649.80       98,340,649.80                  -
  开发支出                                                   -                   -                 -
  商誉                                                       -                   -                 -
  长期待摊费用                                  19,867,123.75       19,867,123.75                  -
  递延所得税资产                                   706,577.52          706,577.52                  -
  其他非流动资产                                             -                   -                 -
    非流动资产合计                           10,209,083,417.16   10,209,083,417.16                 -
     资产总计                                14,605,511,311.21   14,605,511,311.21                 -
流动负债:
  短期借款                                    1,766,632,000.00    1,766,632,000.00                 -
  交易性金融负债                                             -                   -                 -
  以公允价值计量且其变动计入当期损益的                       -                   -                 -
金融负债
  衍生金融负债                                               -                   -                 -
  应付票据及应付账款                          1,742,185,673.58    1,742,185,673.58                 -
  预收款项                                     572,148,056.68      572,148,056.68                  -
  合同负债                                                   -                   -                 -
  应付职工薪酬                                  10,483,128.61       10,483,128.61                  -

                                                21/22
                                     2019 年第一季度报告



  应交税费                                    1,020,982.24        1,020,982.24              -
  其他应付款                               939,819,252.11      939,819,252.11               -
  其中:应付利息                            32,676,312.66       32,676,312.66               -
       应付股利                             12,037,536.00       12,037,536.00               -
  持有待售负债                                           -                   -              -
  一年内到期的非流动负债                  1,899,741,980.25    1,899,741,980.25              -
  其他流动负债                                           -                   -              -
    流动负债合计                          6,932,031,073.47    6,932,031,073.47              -
非流动负债:
  长期借款                                 894,699,000.00      894,699,000.00               -
  应付债券                                               -                   -              -
  其中:优先股                                           -                   -              -
         永续债                                          -                   -              -
  租赁负债                                               -                   -              -
  长期应付款                                             -                   -              -
  预计负债                                               -                   -              -
  递延收益                                               -                   -              -
  递延所得税负债                              3,058,426.31        3,058,426.31              -
  其他非流动负债                                         -                   -              -
    非流动负债合计                         897,757,426.31      897,757,426.31               -
     负债合计                             7,829,788,499.78    7,829,788,499.78              -
所有者权益(或股东权益):
  实收资本(或股本)                      3,108,175,038.00    3,108,175,038.00              -
  其他权益工具                                           -                   -              -
  其中:优先股                                           -                   -              -
         永续债                                          -                   -              -
  资本公积                                2,111,484,781.44    2,111,484,781.44              -
  减:库存股                                73,449,429.00       73,449,429.00               -
  其他综合收益                                           -                   -              -
  盈余公积                                 560,591,076.73      560,591,076.73               -
  未分配利润                              1,068,921,344.26    1,068,921,344.26              -
    所有者权益(或股东权益)合计          6,775,722,811.43    6,775,722,811.43              -
负债和所有者权益(或股东权益)总计       14,605,511,311.21   14,605,511,311.21              -

 各项目调整情况的说明:
 √适用 □不适用
      本公司母公司自 2019 年 1 月 1 日起首次执行新金融工具准则,2019 年度已按照新金融工具
 准则要求,将可供出售金融资产期初余额对应调整至其他权益工具投资项。
 4.3 首次执行新金融工具准则、新租赁准则追溯调整前期比较数据的说明
 □适用 √不适用
 4.4 审计报告
 □适用 √不适用


                                            22/22
数据加载中...
prevnext
手机查看股票